This page shows the latest cancer vaccine news and features for those working in and with pharma, biotech and healthcare.
phase 1 trial evaluating its mRNA-based personalised cancer vaccine. ... We are encouraged by this interim data from our personalised cancer vaccine programme, which involves designing and manufacturing a unique vaccine for each patient based on their
The growth in profits was mainly due to increasing demand for certain drugs, including its blockbuster checkpoint inhibitor Keytruda (pembrolizumab), and its bacterial pneumonia vaccine. ... Merck is currently developing an oral antiviral candidate for
BioNTech has agreed to pay $67m for Cambridge, Massachusetts-based Neon, which ended 2019 on a sour note by dropping its clinical-stage personalised cancer vaccine NEO-PV-01 after disappointing ... Also in the pipeline is NEO-STC-01, another RAS-targeted
At MSD we continue to pursue new regimens designed to extend the benefits of highly selective therapies to more patients with cancer,” said Roger Perlmutter (pictured left), president, MSD Research Laboratories. ... Merck also has an ongoing
He said the performance of other cancer drugs like Lenvima (lenvatinib) and Lynparza (olaparib), revenue from which doubled in the quarter – as well as the vaccine portfolio headed by cervical cancer ... vaccine Gardasil and HIV franchise – is
Cervarix from the US market after finding it was not competitive against rival Merck &Co’s HPV vaccine. ... Innovax has already developed a cervical cancer vaccine, Cecolin, which is HPV 16 &18 bivalent – these two HPV types are known to cause at
More from news
Approximately 2 fully matching, plus 149 partially matching documents found.
You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine for prostate cancer in phase 1. ... How big a role do you think therapeutic vaccines will play in future cancer treatment?
This was the fifth deal announced by AstraZeneca/Medimmune in the month under which the company gained access to INO-3112 a cancer vaccine which targets cancers caused by human papilloma ... Acquisition ‐ company. 847. Inovio. AZ/Medimmune. INO‐3112
The companies will collaborate to develop three anti-cancer drugs, one Mab from Lilly and a Mab and an additional molecule from Innovent. ... This is what BMS has secured with Bavarian Nordic's cancer vaccine targeting PSA in phase III for treatment of
This month saw the deadline, highlighted in January's Deal Watch, for Valeant to acquire Dendreon, and more specifically the dendritic cell, prostate cancer vaccine Provenge (sipuleucel-T), come and go.
R&D and. commercialisation. IMA942 tumour-associated peptide cancer vaccine candidates in NSCLC and prostate cancer. ... BeiGene / Merck. Serono. Co-development. Expansion of collaboration to include BeiGene 290 for cancer.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Cancer vaccine company Dendreon has added to its senior team, appointing Dr Bruce Brown as its new senior vice president, medical. ... stage prostate cancer, with the hope of curing more men of the disease.”.
He joins from EpiTherapeutics where he holds the same role. Norwegian cancer vaccine company Vaccibody has appointed Dr Martin Bonde as CEO, effective from August 10.
The decision comes as Dendreon continues to struggle as its only product Provenge – a 'vaccine' for prostate cancer ' – fails to live up to high expectations. ... a personalised cancer treatment.
prostate cancer vaccine Provenge.
The US biotech, which markets prostate cancer vaccine Provenge (sipuleucel-T), said Rocco will be responsible for all communications functions of the company, reporting directly to chair, president and CEO John ... Lindsay is a seasoned communicator with
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
To date, most of the focus has understandably been on the immediate effects of the virus and the efforts to enforce physical distancing and develop a vaccine.
A good example of this is Globocan cancer epidemiology data, which is extremely high level but does not provide insight as to staging or treatment rates. ... A good example of this “Risk-awareness thinking” would be the impact of the cervical cancer
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...